ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Merus NV

Merus NV (2GH)

42.20
0.80
(1.93%)
Closed December 08 4:00PM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
42.20
Bid
41.80
Ask
42.80
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC Studie mit Petosemtamab in Kombination mit Pembrolizumab bei 1L...

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m...

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1-2.3148148148143.2474319244.19451697DE
4-7.8-15.65051.540.411744.74603537DE
12-3-6.6371681415945.251.540.412747.17167127DE
26-6-12.448132780148.257.540.415948.57608533DE
5219.283.47826086962358.521.39999917344.34418355DE
15618.477.310924369723.858.51916742.00023485DE
26018.477.310924369723.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M
A6NAsana Inc
21.00 €
(43.84%)
19.08k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
13.33k
RQ0DWave Quantum Inc
4.814 €
(34.92%)
1.15M
K8DWellfield Technologies Inc
0.0342 €
(34.65%)
30.8k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
M0YNMynaric AG
1.40 €
(-72.66%)
303.13k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
D7GNel ASA
0.2625 €
(-1.69%)
4.24M
LK1Lake Resources
0.029 €
(-6.75%)
2.32M
TUI1Tui AG
8.40 €
(1.11%)
2.17M
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M

Discussion

View Full Feed
Monroe1 Monroe1 1 minute ago
That's right but that is where socialist take their jabs. Here's another one Commie. This is what America looks like. Head of over to Venezuela or better yet you would like London. Foolish phonies thought they could steal our country by cheating again and get away with it. See what happened LOSERS!!
doc2016 doc2016 2 minutes ago
blockchain distribution based on priorities, mle markup, contractual obligations, sovereign data regulations, etc.
these jobs are part of what the os would need to provide..... wags.

what did portuno say about the data determining the programming/os functionality? I believ
rbl100 rbl100 2 minutes ago
Wow those McRibs are tasty. Have not had their fries since the mid 90's after they switched to frying in toxic cancer causing chronic disease inducing cardiovascular damaging seed (vegetable) oils though. When will they switch back to natural healthy beef tallow?
MCD
mick mick 3 minutes ago
BIRDFLU
https://rumble.com/v5wzmn8-it-begins.....-federal-order-just-signed-today-big-changes-start-on-decembe.html?e9s=src_v1_ucp
krab krab 5 minutes ago
~
FNMA
Number sleven Number sleven 5 minutes ago
North, Do you have any expectations?
Sleven,
AMRN
infamous infamous 5 minutes ago
you all here are concerned IMO more about short term charts. truth is...this company at this level is an INCREDIBLE buy and hold for 2 years. I really beleive
that by end of 2026, this will have gone up over 200%. thoughts?
AMD
eastunder eastunder 5 minutes ago
Earnings 12-8-24

AI 12-9 A
ORCL 12-9 A

GME 12-10 A
PLAY 12-10 A

ADBE 12-11 A

AVGO 12-12 A
COST 12-12 A
RH 12-12 A

MU 12-18 A

NKE 12-19 A
BB 12-19 A
FDX 12-19 A
AAPL ABNB ADBE
Cologne9672 Cologne9672 5 minutes ago
This time of year it’s common for people to believe in things like Santa Claus and flying reindeer. Believing in CRGP is similar to that.
CRGP
Flobewan Flobewan 6 minutes ago
See, she knows how to use her doggie door. Here she is last night at 9:04 pm and we were already upstairs watching TV in bed.
https://ring.com/share/3ee6b1f0-455c-425f-ab76-8d2ac46ceaf4
XMaster2023 XMaster2023 6 minutes ago
Wow, Ex thinks he is smarter than the 73 coauthors who indicated Stat Sig. Ex, what are your credentials to make such a statement? I doubt you even have a Liberal Arts and Science Degree. The Professionals who coauthored also actually provided their name, you can pull up the list. Do you have mor
NWBO
Monksdream Monksdream 6 minutes ago
APDN, new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/12/8/[hmcxIMG_3813.gif
APDN
doc2016 doc2016 6 minutes ago
how might ionq recruit/maintain/operated their os in network?
https://www.nowsolutions.com/services/
hr of people or machines? would seem to be the same components with different object names/functions/meta data?

it's not mumbo jumbo, but seems pretty straightforward?
IONQ
Mdk1 Mdk1 7 minutes ago
Tedpeele and the ‘stubborn’ Retail Longs …

>>> Ah, Tedpeele, our valiant knight of negativity, clanging around in his tin foil armor, trying (and failing) to conquer the unconquerable—retail stubbornness. How's it going on the payroll of your shadowy overlords? Not great, I’d wager. W
LWLG
zdog1954 zdog1954 7 minutes ago
Argh, here I am again reading one of your posts.

I believe the share price shot up initially because Dr. Lebby made clear at the 2021 ASM that they could mass produce modulators using foundries. He made it clear that there would be no large capital influx needed for a production facil
ASM
Monksdream Monksdream 7 minutes ago
MEGL, 10Q due DEC 9
https://investorshub.advfn.com/uimage/uploads/2024/12/8/olrdnIMG_3812.gif
MEGL
Hawk05 Hawk05 9 minutes ago
Did you see what I see?
BIEL
Monksdream Monksdream 10 minutes ago
MOB, 10Q due DEC 10
https://investorshub.advfn.com/uimage/uploads/2024/12/8/srisgIMG_3810.gif
MOB
fuagf fuagf 10 minutes ago
Am only about 5 miles from Sydney center. Am with you in that there is a lot of ordinary stuff on Netflix, but guess that would be the same with all of them. Seriously i would be one of the minority around who doesn't even have cable, just because i can't be bothered with it. Am not into watching
tdbowieknife tdbowieknife 11 minutes ago
And you missed the part where those assets are not part of this "merger".


.

Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG


..
GRLT
doc2016 doc2016 12 minutes ago
duh, forgot........ServiceNow? an 8x8 elevation partner. salesforce is another 8x8 elevation partner and their agent ai effots. add msft teams; and others.

v ip and 8 would seem to be potentially provisioning those partners with some of the important ip. wags.
Monksdream Monksdream 13 minutes ago
MIND, 10Q due DEC 10
https://investorshub.advfn.com/uimage/uploads/2024/12/8/oyijiIMG_3809.gif
MIND
Moonboy1 Moonboy1 13 minutes ago
Like I said both coins I just mentioned are in the green. Doge and Shib just dropped because Bitcoin is down $200. Ridiculous
DOGEUSD
dennisdave dennisdave 14 minutes ago
I dont understand how that would work. According to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, spoofing is "the illegal practice of bidding or offering with intent to cancel before execution. So if NWBO can prove the biddings were fake then it has met that definition. In
NWBO
Stern is Bald Stern is Bald 14 minutes ago
Btw I have never changed my opinion on if you're an idiot... take that as you want it.
FNMA

Your Recent History

Delayed Upgrade Clock